These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2389 related items for PubMed ID: 12827562

  • 21. Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation.
    Yoshizumi T, Taketomi A, Soejima Y, Uchiyama H, Ikegami T, Harada N, Kayashima H, Yamashita Y, Shimada M, Maehara Y.
    Transpl Int; 2008 Jan; 21(1):81-8. PubMed ID: 17887958
    [Abstract] [Full Text] [Related]

  • 22. MELD score predicts 1-year patient survival post-orthotopic liver transplantation.
    Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW.
    Liver Transpl; 2003 May; 9(5):473-6. PubMed ID: 12740789
    [Abstract] [Full Text] [Related]

  • 23. Which score system can best predict recipient outcomes after living donor liver transplantation?
    Chung IS, Park M, Ko JS, Gwak MS, Kim GS, Lee SK.
    Transplant Proc; 2012 Mar; 44(2):393-5. PubMed ID: 22410025
    [Abstract] [Full Text] [Related]

  • 24. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M.
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [Abstract] [Full Text] [Related]

  • 25. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 26. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
    Dulundu E, Sugawara Y, Kishi Y, Akamatsu N, Kaneko J, Makuuchi M.
    Hepatogastroenterology; 2006 Jun; 53(71):781-2. PubMed ID: 17086888
    [Abstract] [Full Text] [Related]

  • 27. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
    Humar A, Beissel J, Crotteau S, Kandaswamy R, Lake J, Payne W.
    Transplantation; 2008 May 27; 85(10):1420-4. PubMed ID: 18497681
    [Abstract] [Full Text] [Related]

  • 28. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function.
    Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Velidedeoglu E, Chapman WC, Markmann JF.
    Transplantation; 2004 Jan 15; 77(1):99-106. PubMed ID: 14724442
    [Abstract] [Full Text] [Related]

  • 29. Combination of extended donor criteria and changes in the Model for End-Stage Liver Disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis.
    Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-Rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F.
    Transplantation; 2007 Mar 15; 83(5):588-92. PubMed ID: 17353779
    [Abstract] [Full Text] [Related]

  • 30. Advanced donor age alone does not affect patient or graft survival after liver transplantation.
    Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC.
    J Am Coll Surg; 2008 Dec 15; 207(6):847-52. PubMed ID: 19183530
    [Abstract] [Full Text] [Related]

  • 31. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL, Martín LG, Martín EE, Pajares Ad, Pérez AM, Seral CC, Marugán RB.
    Transplant Proc; 2005 Nov 15; 37(9):3881-3. PubMed ID: 16386571
    [Abstract] [Full Text] [Related]

  • 32. A high model for end-stage liver disease score should not be considered a contraindication to living donor liver transplantation.
    Poon KS, Chen TH, Jeng LB, Yang HR, Li PC, Lee CC, Yeh CC, Lai HC, Su WP, Peng CY, Chen YF, Ho YJ, Tsai PP.
    Transplant Proc; 2012 Mar 15; 44(2):316-9. PubMed ID: 22410005
    [Abstract] [Full Text] [Related]

  • 33. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.
    Liver Transpl; 2012 Feb 15; 18(2):160-5. PubMed ID: 22006378
    [Abstract] [Full Text] [Related]

  • 34. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
    Maluf DG, Edwards EB, Stravitz RT, Kauffman HM.
    Liver Transpl; 2009 Jun 15; 15(6):592-9. PubMed ID: 19479802
    [Abstract] [Full Text] [Related]

  • 35. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S.
    Liver Transpl; 2007 Oct 15; 13(10):1405-13. PubMed ID: 17902126
    [Abstract] [Full Text] [Related]

  • 36. Higher graft-to-host ratio may decrease posttransplant mortality in patients with a high MELD score.
    Emiroglu R, Yilmaz U, Coskun M, Karakayali H, Haberal M.
    Transplant Proc; 2007 May 15; 39(4):1164-5. PubMed ID: 17524921
    [Abstract] [Full Text] [Related]

  • 37. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 38. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 15; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 39. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults.
    Goldstein MJ, Salame E, Kapur S, Kinkhabwala M, LaPointe-Rudow D, Harren N P P, Lobritto SJ, Russo M, Brown RS, Cataldegirmen G, Weinberg A, Renz JF, Emond JC.
    World J Surg; 2003 Mar 15; 27(3):356-64. PubMed ID: 12607066
    [Abstract] [Full Text] [Related]

  • 40. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.
    Transplantation; 2011 Aug 27; 92(4):453-60. PubMed ID: 21799468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 120.